Health Sciences Acquisitions Corpor... (HSAQ)
$13.31
+2.59 (+24.16%)
Rating:
Recommendation:
-
| Symbol | HSAQ |
|---|---|
| Price | $13.31 |
| Beta | 0.000 |
| Volume Avg. | 0.07M |
| Market Cap | 149.233M |
| Shares () | - |
| 52 Week Range | 9.41-13.8 |
| 1y Target Est | - |
| DCF Unlevered | HSAQ DCF -> | |
|---|---|---|
| DCF Levered | HSAQ LDCF -> | |
| ROE | -5.34% | Neutral |
| ROA | -4.02% | Neutral |
| Operating Margin | - | |
| Debt / Equity | -105.75% | Sell |
| P/E | -532.40 | Strong Sell |
| P/B | -31.48 | Strong Sell |
About
Download (Excel)Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.